academic article

• The Practitioner's Guide to Global Health: an interactive, online, open-access curriculum preparing medical learners for global health experiences..  Medical education online.  23:-. 2018
• Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial..  The Lancet. Oncology.  13:100-110. 2012
• Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial..  The Lancet. Oncology.  13:89-99. 2012
• The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years..  The Journal of infectious diseases.  199:936-944. 2009